Fig. 9From: Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safetyIncreasing efficacy with a slow-release formulation. A long lasting formulation would increase AUC by prolonging time above lethality, without significant increase in the Cmax and theoretically improving the efficacy/safety ratio. AUC area under the curveBack to article page